about
MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferationsThe MTCP-1/c6.1B gene encodes for a cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a t(X;14) translocationDendritic cells: a complex simplicity.Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy.Th1 response and systemic treg deficiency in inclusion body myositis.Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 TherapyTherapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.Depletion of T regulatory cells through selection of CD127-positive cells results in a population enriched in memory T cells: implications for anti-tumor cell therapy.Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation.Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome.Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoterSerum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.Interleukin 2 in the pathogenesis and therapy of type 1 diabetes.Bcl-2 and immunoglobulin gene rearrangements in patients with malaria related chronic splenomegaly.A possible role for IL-17 in Clarkson's disease.Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity.Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders.Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients.Macrophage inflammatory protein-1alpha is induced by human immunodeficiency virus infection of monocyte-derived macrophages.Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV).Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy.Clinical grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene: authors' reponse.Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials.Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.Role of CD4+CD25hiCD127lo/-FoxP3+ regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children.Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.
P50
Q24312836-6E78F4F2-58AD-4CB5-A4D2-AEBD88AC8E7DQ28241475-F2EA5768-1A3C-4DA8-821A-4166AE1E3BABQ34505309-98E5F535-461C-4A8E-81A8-283742D40F28Q34636874-FFD28194-E468-4EF9-B06A-2C7857DA1535Q35110718-1D705E43-C046-42D9-9AFA-6F487C8AD546Q35426986-B7713EB3-3421-4542-8404-6B7E01849581Q36096318-FE6A6E68-B822-46CF-8847-002150732A6CQ36255408-3F8BCD78-1C74-47C6-84B3-266D25ADFC38Q36366589-A93AB4EB-A2CE-45FB-BBBF-BAF94847F3ADQ36633225-C5AF6FDF-BB85-421B-9965-89DC0C00B544Q36694931-9068637E-D19A-4AE7-A98B-55E527FC3C04Q37596980-947E9785-505C-40BC-811A-B47E83061F0FQ38162037-4DCC5CC4-416B-4B58-BE7A-DC7EB6350847Q38262670-8580809C-8F48-4D45-852D-B2F155C60168Q38962541-D9BEB9CC-0BF0-4711-8A0F-C113B77465A0Q40089867-BF94C628-E9DB-42B9-96FE-91277399D484Q40301437-632009BC-ECFD-4234-A162-4E4825ECD835Q42232023-6B3FB1E6-944B-4C6F-A0C5-678106294F9EQ42238468-92FEF89F-5C8B-4407-A56F-538E77BE0C00Q42472173-2EF6430C-BBCE-4053-8FCF-9A7F6829A0C4Q42981202-52429900-A909-4A79-A09A-9B21AE2E37EAQ43042395-9590898C-7449-4C4C-B60D-A148186DB1A6Q43048001-690AEC2C-960E-4125-A49D-C144EB69740EQ43874759-5A816F4B-8AD6-476A-B421-8A93C6D5492DQ44435655-F0F8800B-653B-4792-9564-9C597649DCD0Q44821593-3B22E133-C79E-4108-91F6-D5D0C361E00DQ45283189-9DD8F785-5E1D-4009-B0BA-0230BADC9494Q45395572-B07BC1B3-475E-44CD-B469-A46B8E45FF54Q45747528-2146AC6C-099E-4815-87E2-968B0DF22F3BQ45770728-5CB08F4F-34F9-4A7E-A384-3B00E7F4D939Q45785777-77A91D4B-9150-4C76-9230-794B60337533Q45858740-822B739A-816E-424A-807B-CBB7EEE15C02Q45975141-042733B0-B263-4DA8-9499-2EAC7B6B8AB2Q46491860-D3A59452-DB1B-415A-8816-03B25FD9CEB0Q48279557-9B4BF9D9-A2DB-47A1-8F99-107797B79D0FQ49097779-AD92A7CB-359D-44DE-AEED-647235229B01Q50016549-F837C506-2637-4353-AF93-05445162B1ACQ50559814-D0007221-31A7-4473-8128-981E64829A94Q50591666-0D4E3732-8C4A-47A8-B0DF-7C394D00BBBCQ50759104-926FA772-9C3A-4EF9-8D4E-8595D62C3C8B
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michelle Rosenzwajg
@ast
Michelle Rosenzwajg
@en
Michelle Rosenzwajg
@es
Michelle Rosenzwajg
@nl
Michelle Rosenzwajg
@sl
type
label
Michelle Rosenzwajg
@ast
Michelle Rosenzwajg
@en
Michelle Rosenzwajg
@es
Michelle Rosenzwajg
@nl
Michelle Rosenzwajg
@sl
prefLabel
Michelle Rosenzwajg
@ast
Michelle Rosenzwajg
@en
Michelle Rosenzwajg
@es
Michelle Rosenzwajg
@nl
Michelle Rosenzwajg
@sl
P214
P106
P21
P214
P31
P496
0000-0001-5312-6203
P735
P7859
viaf-196100099